ScholarIQanswers from OpenAlex & ORCID
Marek Ancukiewicz
ResearcherPublications, citations & collaboration network
Marek Ancukiewicz is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Marek Ancukiewicz have?
ScholarIQindexed works
Marek Ancukiewicz has 284 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Marek Ancukiewicz have?
ScholarIQcitation count
Marek Ancukiewicz has 19,524 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Marek Ancukiewicz?
ScholarIQh-index
Marek Ancukiewicz has an h-index of 58 in OpenAlex.
What is the i10-index of Marek Ancukiewicz?
ScholarIQi10-index
Marek Ancukiewicz has an i10-index of 108 in OpenAlex.
What is the OpenAlex record for Marek Ancukiewicz?
ScholarIQopenalex
The OpenAlex for Marek Ancukiewicz is on the source record.
What are the most-cited papers on Marek Ancukiewicz?
ScholarIQmost cited works
Acute kidney injury in patients with acute lung injury: Impact of fluid accumulation on classification of acute kidney injury and associated outcomes*
Kathleen D. Liu, Bruce Thompson, Marek Ancukiewicz, Jay S. Steingrub, Ivor S. Douglas, Michael A. Matthay, Patrick E. Wright, Michael W. Peterson, Peter Rock, Robert C. Hyzy, Antonio Anzueto, Jonathon D. Truwit
TGF-β blockade improves the distribution and efficacy of therapeutics in breast carcinoma by normalizing the tumor stroma
Jieqiong Liu, Shan Liao, Benjamin Diop-Frimpong, Wei Chen, Shom Goel, Kamila Naxerova, Marek Ancukiewicz, Yves Boucher, Rakesh K. Jain, Lei Xu
Long-Term Follow-Up of Patients With Rectal Cancer Managed by Local Excision With and Without Adjuvant Irradiation
Arnab Chakravarti, Carolyn C. Compton, Paul C. Shellito, William C. Wood, Jerome C. Landry, Shelley R. Machuta, Donald Kaufman, Marek Ancukiewicz, Christopher G. Willett
A Phase II and Biomarker Study of Ramucirumab, a Human Monoclonal Antibody Targeting the VEGF Receptor-2, as First-Line Monotherapy in Patients with Advanced Hepatocellular Cancer
Andrew X. Zhu, Richard S. Finn, Mary F. Mulcahy, Jayne Gurtler, Weijing Sun, Jonathan D. Schwartz, Rita P. Dalal, Adarsh Joshi, Rebecca R. Hozak, Yihuan Xu, Marek Ancukiewicz, Rakesh K. Jain, F. Warren Nugent, Dan G. Duda, Keith Stuart